Takotsubo Cardiomyopathy Secondary to Rituximab
- PMID: 33021535
- DOI: 10.1097/MJT.0000000000001239
Takotsubo Cardiomyopathy Secondary to Rituximab
Conflict of interest statement
The authors have no conflicts of interest to declare.
References
-
- Cheungpasitporn W, Kopecky SL, Specks U, et al. Non-ischemic cardiomyopathy after rituximab treatment for membranous nephropathy. J Ren Inj Prev. 2016;6:18–25.
-
- Emer JJ, Claire W. Rituximab: a review of dermatological applications. J Clin Aesthet Dermatol. 2009;2:29–37.
-
- Naqibullah M, Shaker SB, Bach KS, et al. Rituximab-induced interstitial lung disease: five case reports . Eur Clin Respir J. 2015;2. doi:10.3402/ecrj.v2.27178. - DOI
-
- Cersosimo RJ, Monoclonal antibodies in the treatment of cancer, part 2. Am J Health Syst Pharm. 2003;60:1631–1633. quiz 1642-3.
-
- Mohrbacher A. B cell non-Hodgkin's lymphoma: rituximab safety experience. Arthritis Res Ther. 2005;7(suppl 3):S19–S25.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources